For example, US20100316724 relates to the treatment and/or prevention of bronchiolitis obliterans (BO) and/or bronchiolitis obliterans syndrome (BOS) in mammals [24]; WO2004019985 involves the treatment of inflammatory or respiratory tract diseases [25]; US20090088408 relates to drugs used to treat...